Kapila K. Anand - 30 Nov 2023 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Director
Signature
/s/ Catherine S. Powell, as Attorney-in-Fact for Kapila K. Anand
Issuer symbol
ELAN
Transactions as of
30 Nov 2023
Transactions value $
$0
Form type
4
Filing time
04 Dec 2023, 17:34:19 UTC
Previous filing
03 Oct 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +20.4K +44.18% $0.00 66.5K 30 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.